Intracellular Delivery of Biologically-Active Fungal Metabolite Gliotoxin Using Magnetic Nanoparticles
| dc.contributor.affiliation | Universidade de Santiago de Compostela. Centro de Investigación en Química Biolóxica e Materiais Moleculares | gl |
| dc.contributor.author | Comas, Laura | |
| dc.contributor.author | Polo Tobajas, Ester | |
| dc.contributor.author | Domingo, M. Pilar | |
| dc.contributor.author | Hernández, Yulán | |
| dc.contributor.author | Arias, Maykel | |
| dc.contributor.author | Esteban, Patricia | |
| dc.contributor.author | Martínez-Lostao, Luis | |
| dc.contributor.author | Pardo, Julián | |
| dc.contributor.author | Martínez de la Fuente, Jesús | |
| dc.contributor.author | Gálvez, Eva M. | |
| dc.date.accessioned | 2019-09-11T08:58:31Z | |
| dc.date.available | 2019-09-11T08:58:31Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Gliotoxin (GT), a secondary metabolite produced by Aspergillus molds, has been proposed as a potential anti-tumor agent. Here we have developed a nanoparticle approach to enhance delivery of GT in tumor cells and establish a basis for its potential use as therapeutical drug. GT bound to magnetic nanoparticles (MNPs) retained a high anti-tumor activity, correlating with efficient intracellular delivery, which was increased in the presence of glucose. Our results show that the attachment of GT to MNPs by covalent bonding enhances intracellular GT delivery without affecting its biological activity. This finding represents the first step to use this potent anti-tumor agent in the treatment of cancer | gl |
| dc.description.peerreviewed | SI | gl |
| dc.description.sponsorship | This work was supported by Fondo Social Europeo (FSE; Gobierno de Aragón), ASPANOA and by grants SAF2017-83120-C2-1-R, SAF2014-54763-C2-1-R, SAF2014-54763-C2-2-R from Spanish Ministry of Economy and Competitivenes. LC was granted by a DGA predoctoral contract, EP by a Juan de la Cierva Incorporacion fellowship program (IJCI-2016-30706) and MA by a Juan de la Cierva Formación fellowship program (FJCI-2017-31629) | gl |
| dc.identifier.citation | Comas, L.; Polo, E.; Domingo, M.P.; Hernández, Y.; Arias, M.; Esteban, P.; Martínez-Lostao, L.; Pardo, J.; Martínez de la Fuente, J.; Gálvez, E.M. Intracellular Delivery of Biologically-Active Fungal Metabolite Gliotoxin Using Magnetic Nanoparticles. Materials 2019, 12, 1092 | gl |
| dc.identifier.doi | 10.3390/ma12071092 | |
| dc.identifier.issn | 1996-1944 | |
| dc.identifier.uri | http://hdl.handle.net/10347/19757 | |
| dc.language.iso | eng | gl |
| dc.publisher | MDPI | gl |
| dc.relation.publisherversion | https://doi.org/10.3390/ma12071092 | gl |
| dc.rights | © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/) | gl |
| dc.rights | Atribución 4.0 Internacional | |
| dc.rights.accessRights | open access | gl |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | Magnetic nanoparticles | gl |
| dc.subject | Gliotoxin | gl |
| dc.subject | Therapeutic | gl |
| dc.subject | Drug delivery | gl |
| dc.subject | Cancer cells | gl |
| dc.title | Intracellular Delivery of Biologically-Active Fungal Metabolite Gliotoxin Using Magnetic Nanoparticles | gl |
| dc.type | journal article | gl |
| dc.type.hasVersion | VoR | gl |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 8b9beb32-7cfc-4c41-871e-f0960dcb60e3 | |
| relation.isAuthorOfPublication.latestForDiscovery | 8b9beb32-7cfc-4c41-871e-f0960dcb60e3 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2019_materials_comas_intracellular.pdf
- Size:
- 3.91 MB
- Format:
- Adobe Portable Document Format
- Description: